cifenline has been researched along with Cardiac Failure in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cibenzoline dosing is generally based on renal function, but serum concentrations might be greater than the expected therapeutic levels when standard oral dosing is used." | 1.33 | Heart failure elevates serum levels of cibenzoline in arrhythmic patients. ( Kamakura, S; Kitakaze, M; Komamura, K; Kotake, T; Miyatake, K; Morishita, H; Takada, M, 2006) |
| " Resulting plasma concentration-time profiles and urinary excretion rate data were used to determine pharmacokinetic parameters for cibenzoline." | 1.27 | Effect of congestive heart failure on the pharmacokinetics of cibenzoline. ( DeGrazia, F; Keefe, D; Massarella, JW; Miwa, B; Silvestri, T, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M | 1 |
| Ikeda, S | 1 |
| Shigematsu, Y | 1 |
| Kotake, T | 1 |
| Takada, M | 1 |
| Komamura, K | 1 |
| Kamakura, S | 1 |
| Miyatake, K | 1 |
| Kitakaze, M | 1 |
| Morishita, H | 1 |
| Massarella, JW | 1 |
| Silvestri, T | 1 |
| DeGrazia, F | 1 |
| Miwa, B | 1 |
| Keefe, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial[NCT02948998] | Phase 4 | 260 participants (Anticipated) | Interventional | 2018-05-14 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cifenline and Cardiac Failure
| Article | Year |
|---|---|
Advances in medical treatment of hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blocke | 2014 |
2 other studies available for cifenline and Cardiac Failure
| Article | Year |
|---|---|
Heart failure elevates serum levels of cibenzoline in arrhythmic patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Body Weight; Drug Evaluation; Female; Heart | 2006 |
Effect of congestive heart failure on the pharmacokinetics of cibenzoline.
Topics: Aged; Biological Availability; Blood Pressure; Heart Failure; Heart Rate; Humans; Imidazoles; Male; | 1987 |